跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP - HSA Drug Approval Details
Approvals
/
HSA
/
COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
Approved
THERAPEUTIC
COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
BAXTER HEALTHCARE PTY LTD (AUSTRALIA)
🇸🇬 Health Sciences Authority
Approval Date
Jul 3, 1991
Approval ID
beaa204b5120fd7f
Company
BAXTER HEALTHCARE PTY LTD (AUSTRALIA)
Type
Therapeutic
Approval Details
Approval Id
beaa204b5120fd7f
Drug Name
COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
Product Name
COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
Approval Number
SIN06392P
Approval Date
1991-07-03
Registrant
BAXTER HEALTHCARE (ASIA) PTE LTD
Licence Holder
BAXTER HEALTHCARE (ASIA) PTE LTD
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS
Atc Code
B05BB01
Atc Item Name
electrolytes
Pharma Manufacturer Name
BAXTER HEALTHCARE (ASIA) PTE LTD
Company Detail Path
/organization/baxter-healthcare-asia-pte-ltd
Active Ingredients
SODIUM CHLORIDE
6 g/l
CALCIUM CHLORIDE DIHYDRATE
270 mg/l
POTASSIUM CHLORIDE
400 mg/l
SODIUM LACTATE
3.22 g/l
CALCIUM CHLORIDE DIHYDRATE
270 MG/L
POTASSIUM CHLORIDE
400 MG/L
SODIUM CHLORIDE
6 G/L
SODIUM LACTATE
3.22 G/L
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 3, 1991
Approval ID
beaa204b5120fd7f
Type
Therapeutic
Back to HSA Approvals
